Yabao Pharmaceutical Group Co. Ltd.SSE: 600351

Announcement on Implementation of Dividend Distribution for 2025

Jun 9, 2026 · Issued by Yabao Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 9, 2026 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2025-32

Release

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Yabao Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Yabao Pharmaceutical

Announcement on Election of Employee Representative Director for the 10th SessionJun 5
Announcement on Resolutions of the 15th Meeting of the 9th Board of DirectorsMay 29
Announcement on the Wholly-owned Subsidiary Obtaining Drug Registration CertificateMay 23
Announcement on Attending 2026 Online Collective Reception Day for Investors of Listed Companies in Shanxi JurisdictionMay 16
Announcement on Purchasing Liability Insurance for Directors and Senior Management MembersMay 8

Later from Yabao Pharmaceutical

Announcement on Convening Performance Briefing for 2025 and Q1 2026Jun 13
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Jun 17
Announcement on Obtaining Notice of Approval for Drug Clinical Trials of Scopolamine Transdermal PatchJun 26
Announcement on Obtaining Drug Registration CertificateJul 3
Announcement on Share Repurchase Plan through Call Auction and the Repurchase ReportAug 1

All Yabao Pharmaceutical news releases

Follow Yabao Pharmaceutical into a list and get an email when it puts out news.

Follow Yabao Pharmaceutical